Nos Publications
MELISSA : Laser ion source setup at CERN-MEDICIS facility. Blueprint, Gadelshin VM, Barozier V, Cocolios TE, Fedosseev VN, Formento-Cavaier R, Haddad F, et al., Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. janv 2020;463:460‑3. https://doi.org/10.1016/j.nimb.2019.04.024
Arronax a facility to produce nonstandard radionuclides and radiopharmaceuticals. 17th International Workshop on Targetry and Target Chemistry (WTTC17), 27-31 Aout 2018
T. Sounalet Use of electrodeposition for manufacturing of target 17th International Workshop on Targetry and Target Chemistry (WTTC17), 27-31 Aout 2018
Very high specific activity Er169 production, R. Formento et al. Conference EMIS 2018 16-21 septembre (CERN geneve Suisse)
Production of alpha emitting isotopes: can we get enough? Haddad F. Precongress Symposium EANM Alpha-endoradiotherapy in solid tumors, Düsseldorf, Germany, oct 13 2018(invited)
Présentation d’Arronax et Production de Radionucléides Médicaux, Haddad F, Rencontres Accélérateurs 2018, Saint-Herblain, France, october 8-9 2018. (invited)
Le scandium : un élément à fort potentiel pour la médecine nucléaire, Haddad F, Club Français des Radiopharmaceutiques, Montpellier, France, May 17-18, 2018 (invited)
Promising Scandium Radionuclides for Nuclear Medicine: A Review on the Production and Chemistry up to In Vivo Proofs of Concept, Huclier-Markai S, Alliot C, Kerdjoudj R, Mougin-Degraef M, Chouin N, Haddad F. Cancer Biother Radiopharm. 2018, 33: 316-329
Alphatherapy, the new impetus to targeted radionuclide therapy? Chatal JF, Kraeber-Bodéré F, Chérel M, Haddad F, Eur J Nucl Med Mol Imaging 2018, 45:1362-1363
M. Maietta, R. Cavaier and the MEDICIS collaboration, MEDICIS-PROMED : INNOVATIVE RADIONUCLIDES FOR MEDICINE APPLICATIONS, 9ICI, Doha, Qatar,10-14 Novembre 2017